Reed's, Inc. Announces Board of Director Nominees
Oct 31, 2016 12:31 pm UTC| Business
LOS ANGELES, Oct. 31, 2016 -- (NYSE-MKT:REED), maker of the top selling craft sodas nationwide announced today that the Board of Directors has named its slate of Directors for consideration for election at its 2016...
PositiveID’s E-N-G Mobile Systems’ Service Business in Q3 Grew 70% over the First Half of 2016
Oct 31, 2016 12:31 pm UTC| Business
DELRAY BEACH, Fla., Oct. 31, 2016 -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today that the service business at its E-N-G...
PositiveID’s E-N-G Mobile Systems’ Service Business in Q3 Grew 70% over the First Half of 2016
Oct 31, 2016 12:31 pm UTC| Business
DELRAY BEACH, Fla., Oct. 31, 2016 -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today that the service business at its E-N-G...
Oct 31, 2016 12:31 pm UTC| Business
51% of patients in the high responder subset receiving Ampligen vs. 18% of placebo patients demonstrated improvement of at least 25% in exercise tolerance ...
SteadyMed to Present at the 25th Annual Credit Suisse Healthcare Conference
Oct 31, 2016 12:30 pm UTC| Business
SAN RAMON, Calif., Oct. 31, 2016 -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with unmet parenteral...
BIOSSANCE™ to Launch in Sephora Stores
Oct 31, 2016 12:30 pm UTC| Business
EMERYVILLE, Calif., Oct. 31, 2016 -- Biossance™, the consumer beauty brand from Amyris, Inc. (NASDAQ:AMRS), today announced its planned launch in Sephora’s retail stores where the brand’s expansive line of...
Versartis to Present at Two Investor Conferences in November
Oct 31, 2016 12:30 pm UTC| Business
MENLO PARK, Calif., Oct. 31, 2016 -- Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused biopharmaceutical company that is developing somavaratan (VRS-317), a novel, long-acting form of recombinant human growth hormone...
U.S. payrolls exceeded expectations significantly, while the unemployment rate dropps to 4.1%.